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Abstract
The anti-tumor effect of immunization with heat-killed Mycobacterium tuberculosis (Tbc)
and Tuberculin (PPD)-coupled syngeneic tumor cells was examined in vivo. Three tumor cell
lines were employed. Immunization of Tbc-primed BALB/c mice with PPD-coupled syngeneic
Meth-A tumor cells displayed a potent anti-tumor effect on viable Meth-A cells inoculated subcu-
taneously. Neither PPD-coupled LLC (Lewis Lung Carcinoma) cells nor sonicated PPD-coupled
Meth-A cells were capable of immunizing these mice. PPD-coupled syngeneic whole tumor cells
were indispensable for induction of this tumor-specific resistance. Immunization of Tbc-primed
C3H/He mice with PPD-coupled syngeneic MH134 tumor cells did not elicit anti-tumor activity
against MH134, but additional pretreatment of mice with cyclophosphamide brought on an anti-
tumor effect. Antimetastatic reactivity was investigated in C57BL/6 mice bearing LLC, with a
reduction in metastases noted. This antimetastatic effect was observed even when the mice were
immunized with PPD-coupled LLC cells three days after removal of the initial tumor. Immu-
nization with Tbc and PPD-coupled Meth-A cells together with intraperitoneal administration of
murine or rat interleukin 2 (IL 2) further augmented anti-Meth-A resistance. Murine IL 2 fur-
ther inhibited tumor growth during the early stage, while rat IL 2 showed an anti-tumor effect
throughout the course of tumor growth.
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